Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

Benzinga Newsdesk www.benzinga.com Positive 78.2%

Neg 0% Neu 0% Pos 78.2%

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $140 to $144.